BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27639430)

  • 1. Prognostic factors and survival in non-central nervous system rhabdoid tumors.
    Farber BA; Shukla N; Lim II; Murphy JM; La Quaglia MP
    J Pediatr Surg; 2017 Mar; 52(3):373-376. PubMed ID: 27639430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system atypical teratoid rhabdoid tumours: the Canadian Paediatric Brain Tumour Consortium experience.
    Lafay-Cousin L; Hawkins C; Carret AS; Johnston D; Zelcer S; Wilson B; Jabado N; Scheinemann K; Eisenstat D; Fryer C; Fleming A; Mpofu C; Larouche V; Strother D; Bouffet E; Huang A
    Eur J Cancer; 2012 Feb; 48(3):353-9. PubMed ID: 22023887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Affecting the Outcomes of Patients with Malignant Rhabdoid Tumors: A Population-Based Study.
    Cai W; Liu X; Ge W; Wu D; Xu J; Bai R; Hu H
    Int J Med Sci; 2021; 18(4):911-920. PubMed ID: 33456348
    [No Abstract]   [Full Text] [Related]  

  • 4. Rhabdoid tumor: the Irish experience 1986-2013.
    Uwineza A; Gill H; Buckley P; Owens C; Capra M; O'Sullivan C; McDermott M; Brett F; Farrell M; Pears J; O'Sullivan MJ
    Cancer Genet; 2014 Sep; 207(9):398-402. PubMed ID: 25085603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in Germany.
    Reinhard H; Reinert J; Beier R; Furtwängler R; Alkasser M; Rutkowski S; Frühwald M; Koscielniak E; Leuschner I; Kaatsch P; Graf N
    Oncol Rep; 2008 Mar; 19(3):819-23. PubMed ID: 18288421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study.
    Dufour C; Beaugrand A; Le Deley MC; Bourdeaut F; André N; Leblond P; Bertozzi AI; Frappaz D; Rialland X; Fouyssac F; Edan C; Grill J; Quidot M; Varlet P
    Cancer; 2012 Aug; 118(15):3812-21. PubMed ID: 22180295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience.
    Zaky W; Dhall G; Ji L; Haley K; Allen J; Atlas M; Bertolone S; Cornelius A; Gardner S; Patel R; Pradhan K; Shen V; Thompson S; Torkildson J; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2014 Jan; 61(1):95-101. PubMed ID: 23934933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience.
    Furtwängler R; Kager L; Melchior P; Rübe C; Ebinger M; Nourkami-Tutdibi N; Niggli F; Warmann S; Hubertus J; Amman G; Leuschner I; Vokuhl C; Graf N; Frühwald MC
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28843054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors.
    Sultan I; Qaddoumi I; Rodríguez-Galindo C; Nassan AA; Ghandour K; Al-Hussaini M
    Pediatr Blood Cancer; 2010 Jan; 54(1):35-40. PubMed ID: 19798737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous Central Nervous System Atypical Teratoid/Rhabdoid Tumor and Malignant Rhabdoid Tumor of the Kidney: Case Report of a Long-Term Survivor and Review of the Literature.
    Abu Arja MH; Patel P; Shah SH; Auletta JJ; Meyer EK; Conley SE; Aldrink JH; Pindrik JA; AbdelBaki MS
    World Neurosurg; 2018 Mar; 111():6-15. PubMed ID: 29223518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013.
    Bourdeaut F; Chi SN; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):346-51. PubMed ID: 25468731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic determinants in epithelioid sarcoma.
    Gasparini P; Facchinetti F; Boeri M; Lorenzetto E; Livio A; Gronchi A; Ferrari A; Massimino M; Spreafico F; Giangaspero F; Forni M; Maestro R; Alaggio R; Pilotti S; Collini P; Modena P; Sozzi G
    Eur J Cancer; 2011 Jan; 47(2):287-95. PubMed ID: 20932739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdoid tumor of the liver: Report of 6 pediatric cases treated at a single institute.
    Cornet M; De Lambert G; Pariente D; Planchon JM; Guettier C; Martelli H; Guérin F; Branchereau S
    J Pediatr Surg; 2018 Mar; 53(3):567-571. PubMed ID: 28966010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose alkylator therapy for extracranial malignant rhabdoid tumors in children.
    Venkatramani R; Shoureshi P; Malvar J; Zhou S; Mascarenhas L
    Pediatr Blood Cancer; 2014 Aug; 61(8):1357-61. PubMed ID: 24789740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
    Tekautz TM; Fuller CE; Blaney S; Fouladi M; Broniscer A; Merchant TE; Krasin M; Dalton J; Hale G; Kun LE; Wallace D; Gilbertson RJ; Gajjar A
    J Clin Oncol; 2005 Mar; 23(7):1491-9. PubMed ID: 15735125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?
    Rizzo D; Fréneaux P; Brisse H; Louvrier C; Lequin D; Nicolas A; Ranchère D; Verkarre V; Jouvet A; Dufour C; Edan C; Stéphan JL; Orbach D; Sarnacki S; Pierron G; Parfait B; Peuchmaur M; Delattre O; Bourdeaut F
    Am J Surg Pathol; 2012 Jul; 36(7):964-72. PubMed ID: 22614000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor.
    Seeringer A; Reinhard H; Hasselblatt M; Schneppenheim R; Siebert R; Bartelheim K; Leuschner I; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):429-33. PubMed ID: 25262118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical teratoid/rhabdoid tumours: clinicopathological characteristics, prognostic factors and outcomes of 22 children from 2010 to 2015 in China.
    Wang RF; Guan WB; Yan Y; Jiang B; Ma J; Jiang MW; Wang LF
    Pathology; 2016 Oct; 48(6):555-63. PubMed ID: 27558890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhabdoid tumor predisposition syndrome.
    Sredni ST; Tomita T
    Pediatr Dev Pathol; 2015; 18(1):49-58. PubMed ID: 25494491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.